Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction
Patrick Most(Thomas Jefferson University), Walter J. Koch(Temple University), Hanna Seifert(Thomas Jefferson University), Erhe Gao(Temple University), Andrea D. Eckhart(Thomas Jefferson University), Andrew Remppis(Heidelberg University), Hajime Funakoshi(Thomas Jefferson University), Sven T. Pleger(Thomas Jefferson University), Jörg Heierhorst(St Vincents Institute of Medical Research), Arthur M. Feldman(Temple University), Brent R. DeGeorge(Thomas Jefferson University), Mirko Völkers(German Cancer Research Center)
Cited by 145
Related Papers
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Adrenergic Nervous System in Heart Failure
|Circulation Research|2013|597
A novel protective effect of erythropoietin in the infarcted heart
|Journal of Clinical Investigation|2003|549
Myocardial AKT: The Omnipresent Nexus
|Physiological Reviews|2011|222